Innovent Biologics, Inc. (IVBXF)
10.22
+0.04
(+0.39%)
USD |
OTCM |
Feb 06, 16:00
Innovent Biologics Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CSPC Pharmaceutical Group Ltd. | 13.93B |
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | 33.17M |
| Zai Lab Ltd. | 1.419B |
| WuXi Biologics (Cayman), Inc. | -- |
Enterprise Value Related Metrics
| Earnings Yield | 0.91% |
| Operating Earnings Yield | 1.43% |
| Normalized Earnings Yield | 0.8327 |